Companies / Precision BioSciences, Inc.
Precision BioSciences, Inc.
Nasdaq: DTILCIK 1357874DURHAM, NC
Financials · FY2025
Ownership
27.6M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 2.76% | 761,530 |
| 10%+ / strategic | 16.18% | 4,467,088 |
| Institutions | 47.14% | 13,012,253 |
| Public float | 33.91% | 9,360,683 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Amoroso MichaelCEOPresident and CEO · Director | 0.88% | 243,392 |
Kelly John AlexanderChief Financial Officer | 0.46% | 125,883 |
Smith J. JeffersonChief Research Officer | 0.44% | 121,926 |
Scimeca DarioGeneral Counsel and Secretary | 0.20% | 56,457 |
Buehler KevinDirector | 0.18% | 49,137 |
Germano Geno JDirector | 0.16% | 44,883 |
Brown MelindaDirector | 0.16% | 44,346 |
Frankel StanleyDirector | 0.15% | 40,478 |
Pire Shari LisaDirector | 0.13% | 35,028 |
Institutional holders 72
View all →| Holder | Value | % of shares |
|---|---|---|
| $9.22M | 4.25% | |
| $9.13M | 7.95% | |
| $8.90M | 7.75% | |
| $7.98M | 6.95% | |
| $6.92M | 6.02% | |
| $4.43M | 3.86% | |
| $4.13M | 3.60% | |
| $3.77M | 3.29% | |
| $3.36M | 1.55% | |
| $3.32M | 2.89% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Amoroso Michael CEO | Sell | Common Stock | $145.1K | -35K -15.07% | 196,154 0.71% of shares | medium |
| Feb 18, 2026 | Amoroso Michael CEO | Sell | Common Stock | $78.9K | -21K -7.79% | 243,392 0.88% of shares | low |
| Jan 21, 2026 | Kelly John Alexander Executive | Sell | Common Stock | $61.3K | -15K -12.50% | 106,448 0.39% of shares | low |
| Jan 21, 2026 | Smith J. Jefferson Executive | Sell | Common Stock | $41.1K | -10K -8.47% | 110,184 0.40% of shares | low |
| Jan 21, 2026 | Scimeca Dario Executive | Sell | Common Stock | $35.7K | -9K -16.53% | 44,715 0.16% of shares | low |
| Feb 18, 2026 | Kelly John Alexander Executive | Sell | Common Stock | $31.3K | -8K -6.08% | 125,883 0.46% of shares | low |
| Feb 18, 2026 | Scimeca Dario Executive | Sell | Common Stock | $18.9K | -5K -8.02% | 56,457 0.20% of shares | low |
| Feb 18, 2026 | Smith J. Jefferson Executive | Sell | Common Stock | $18.9K | -5K -3.88% | 121,926 0.44% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Tang Capital Management, LLC | Passive13G/A | — |
| Bleichroeder LP | Passive13G/A | — |
| Lynx1 Capital Management LP | Passive13G/A | — |
| Empery Asset Management, LP | Passive13G | — |
| Aberdeen Group plc | Passive13G | — |
| Octagon Capital Advisors LP | Passive13G | — |
| Empery Asset Management, LP | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| DTIL | — | 74019P207 |